Company
United StatesPublic company, NYSE: PFEPfizer Inc. (NYSE: PFE), Parsippany, NJ – FDA Inspections
Inspection records and compliance data for Pfizer Inc. in Parsippany, New Jersey. 6 FDA inspections on record, 1 Form 483, last inspected September 29, 2026. Publicly traded as NYSE: PFE.
Company Profile
This profile covers Pfizer Inc. based in Parsippany, New Jersey, United States.
FDA Inspection History
- FDA inspections
- 6
- OAI
- 0
- VAI
- 0
- NAI
- 4
- Unclassified
- 2
- Form 483s
- 1
- Warning letters
- 0
First inspected March 11, 2011. Last inspected September 29, 2026.
Most cited issue areas
- Failure to comply with REMS Implementation System1 inspection
FDA inspections (6)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| September 29, 2026 | Not classified | Human Drugs · Postmarket Surv. and Epidemiology | 1338628 |
| June 18, 2025 | Not classified | Human Drugs | 1256978 |
| September 28, 2022 | NAI | Human Drugs · Drug Quality Assurance | 1181324 |
| June 2, 2016 | NAI | Human Drugs · Drug Quality Assurance | 971684 |
| September 5, 2013 | NAI | Human Drugs · Drug Quality Assurance | 847159 |
| March 11, 2011 | NAI | Human Drugs · Drug Quality Assurance | 714537 |
FDA documents
EIRs (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Pfizer Inc.
Stock ticker
PFE
Exchange
NYSE
Share price
$28.84
Market cap
$164.4B
Price as of
November 13, 2026
FEI Number
3003836868
Address
400 Webro Rd, Parsippany, New Jersey 07054, United States
Country
United States
ID: 95f0f34c-638b-4a6b-8c65-35fb37711e6b